Takuya Kishimoto

Title: Takuya Kishimoto: Innovator in Therapeutic Compounds

Introduction

Takuya Kishimoto is a notable inventor based in Fujimino, Japan. He has made significant contributions to the field of therapeutic agents, particularly in the development of compounds that address itching and pruritus. With a total of 2 patents, his work has the potential to impact various medical treatments.

Latest Patents

Kishimoto's latest patents include a compound known as 4-(2-furoyl)aminopiperidine, which is useful as a therapeutic agent for itching. This compound is represented by a specific general formula and exhibits pruritus-inhibiting action. It is particularly beneficial for preventing itching caused by insect bites, environmental allergens, skin infections, and even for patients undergoing renal dialysis. Another patent focuses on 4-(2-furoyl)aminopiperidines, detailing their synthesis, intermediates, and medicinal uses. These derivatives possess opioid μ antagonistic activity, making them useful for treating side effects associated with μ receptor agonists, such as constipation and nausea.

Career Highlights

Throughout his career, Takuya Kishimoto has worked with prominent companies in the pharmaceutical industry, including Kyorin Pharmaceutical Co., Ltd. and Nisshin Seifun Group Inc. His expertise in developing therapeutic compounds has positioned him as a valuable asset in the field of medicinal chemistry.

Collaborations

Kishimoto has collaborated with several professionals in his field, including Rie Shibayama and Yukiko Muraki. These collaborations have likely contributed to the innovative nature of his work and the successful development of his patented compounds.

Conclusion

Takuya Kishimoto's contributions to the field of therapeutic agents highlight his innovative spirit and dedication to improving medical treatments. His patents reflect a commitment to addressing significant health issues, particularly those related to itching and pruritus.